Forest Laboratories is close to an agreement to buy New Jersey-based specialty pharmaceutical company Aptalis Holdings from private equity firm TPG Capital. Forest will pay $3 billion for Aptalis.
Healthcare Health/Fitness
Symphony Technology Group, Evidera purchase Kaiser Permanente subsidiary Archimedes
Private equity firm Symphony Technology Group or STG and its portfolio firm Evidera said they had purchased healthcare modeling company Archimedes for an undisclosed amount.
Bain Capital Ventures, Spectrum Equity take purchase minority stake in MedHOK
Bain Capital Ventures and Spectrum Equity have obtained minority stakes in healthcare software provider MedHOK or Medical House of Knowledge in a $77.5 million deal, Reuters reported.
Medypal bags $400K in seed funding for more affordable healthcare in India
Bangalore, India-based healthcare marketplace Medypal bagged $400,000 in a seed funding round from Unitus Seed Fund to help patients in the country find good and affordable service providers.
AstraZeneca strikes deal with biotech firm Immunocore to develop cancer drug
AstraZeneca's MedImmune unit has partnered with Immunocore, a private British biotechnology company, to develop a cancer drug that would tap on the body's immune system, Reuters reported.
Latest News
Northern Virginia-based private equity investment manager has invested an undisclosed amount in Nexercise, a Maryland-based free motivational health and fitness app for iPhone and Android.
The healthcare unit of Connecticut-based conglomerate General Electric Co (GE) agreed to acquire several life-science assets from Pennsylvania-based laboratory firm Thermo Fisher Scientific Inc in a deal that totals $1.06 billion.
Arseus, a Belgium-based healthcare group, said it has sold its Dentals software Julie, Arseus Dental Lab, Arseus Dental Solutions Benelux and Arseus Dental Solutions France Ouest to Henry Schein Inc for €50 million.
Private equity funds Carlyle Group LP and KKR & Co are in discussion to purchase troubled Brazil-based medical services provider Fleury SA in a deal worth BRL2.9 billion ($1.2 billion), according to three sources familiar with the matter.
GlaxoSmithKline has asked for the approval of India's Foreign Investment Promotion Board for its planned acquisition of a 24.33% stake in its Indian arm GlaxoSmithKline Pharmaceuticals Ltd. GSK will fund the stake hike by investing INR6,400 crore.
Herzaliya, Israel-based National ID Electronic Intelligence solutions provider SuperCom announced the completion of its purchase of the Smart ID division of On Track Innovations.
IMS Health Holdings, which is backed by private equity fund TPG Capital Funds LP, Leonard Green & Partners LP and pension fund Canada Pension Plan Investment Board, said in a filing with the US Securities and Exchange Commission that it intends to raise as much as $100 million in a listing at the New York Stock Exchange.
Australia-based protective clothing manufacturer Ansell Ltd has completed the purchase of US-based firm BarrierSafe Solutions International in a deal valued at $615 million (A$692.29 million).
Cyprotex, a drug testing company based in the UK, on Thursday announced that it had purchased American rival CeeTox. Cyprotex will initially pay £630,000 to the North American Science Associates for CeeTox.
